Showing results (761-770 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|January 31, 2024
Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trialAdrie Bekker, Nicolas Salvadori, Helena Rabie, et al.
The Lancet. HIV|February 1, 2024
Impact of HIV self-testing for oral pre-exposure prophylaxis scale-up on drug resistance and HIV outcomes in western Kenya: a modelling studySarah N Cox, Linxuan Wu, Rachel Wittenauer, et al.
The Lancet. HIV|October 14, 2024
Safety and efficacy of iron supplementation with 3 months of daily ferrous sulphate in children living with HIV and mild-to-moderate anaemia in Uganda: a double-blind, randomised, placebo-controlled trialAnne E P Frosch, Victor Musiime, Christopher Staley, et al.
The Lancet. HIV|August 19, 2024
The long wait for long-acting HIV prevention and treatment formulationsWillem Daniel Francois Venter, Monica Gandhi, Simiso Sokhela, et al.
The Lancet. HIV|August 4, 2024
Impact of financial incentives on viral suppression among adults initiating HIV treatment in Tanzania: a hybrid effectiveness-implementation trialProsper F Njau, Emmanuel Katabaro, Solis Winters, et al.
The Lancet. HIV|July 26, 2024
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortiumLouise Kuhn, Shaun Barnabas, Nicola Cotugno, et al.
The Lancet. HIV|May 23, 2025
Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adultsRichard L Wu, Katherine V Houser, Martin R Gaudinski, et al.
The Lancet. HIV|May 11, 2025
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trialEthel D Weld, Trevor Beattie, Jayajothi Moodley, et al.
The Lancet. HIV|May 10, 2025
Lifestyle modification programme for people living with HIV with metabolic dysfunction-associated steatotic liver disease: a randomised controlled trialGuanlin Li, Vincent Wai-Sun Wong, Ruth Suk-Mei Chan, et al.
The Lancet. HIV|May 2, 2025
Acceptability, feasibility, and effectiveness of caregiver-assisted HIV self-testing among children using an oral mucosal test in Uganda and Zambia: a prospective interventional studyJessica Gross, Nazarius M Tumwesigye, Simon Mutembo, et al.
Pageof 79